Director of Oncology
Dr. Willumsen joined Nordic Bioscience in 2012 and assumed the position of department head in oncology in 2016. His research group focuses on the development of blood-based biomarkers to quantify tumor matrix in serum of cancer patients to understand pharmacodynamics/efficacy/resistance mechanisms of treatments. The group's research activities range from biomarker discovery to preclinical and clinical validation of results. In 2022, Dr. Willumsen was appointed as Director of Oncology.
H-index: 21. i10-index: 40. Citations: 1453 as of March 2023.
Please don't hesitate to contact us if you have any questions or other inquiries.